Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 12, 1996, Pages 4249-4257

  Chapman, Ian M ^a   Bach, Mark A ^b   Van Cauter, Eve ^c   Farmer, Mildred ^d   Krupa, David ^b   Taylor, Alice M ^b   Schilling, Lisa M ^c   Cole, Katrina Y ^c   Skiles, Emily H ^a   Pezzoli, Suzan S ^a   Hartman, Mark L ^a   Veldhuis, Johannes D ^a   Gormley, Glenn J ^b   Thorner, Michael O ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d ICSL Clinical Studies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; HYDROCORTISONE; IBUTAMOREN; PLACEBO; PROLACTIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GROWTH HORMONE; HUMANS; INDOLES; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; SPIRO COMPOUNDS;

EID: 10544241186     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.12.4249     Document Type: Article

References (49)

1. Thorner MO, Vance ML, Horvath E, Kovacs K. 1991 The anterior pituitary. In: Wilson JD, Foster DW, eds. Williams' textbook of endocrinology, 7th ed. Philadelphia: Saunders; 221-310.
2. De Boer H, Blok G-J, Van Der Veen EA. 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 16:63-86.
3. Rosen T, Bengtsson BA. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:285-288.
4. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 64:51-58.
5. van Coevorden A, Mockel J, Laurent E, et al. 1991 Neuroendocrine rhythms and sleep in aging men. Am J Physiol. 260:E651-E661.
6. Veldhuis JD, Liem AY, South S, et al. 1995 Differential impact of age, sex-steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab. 80:3209-3222.
7. Zadik Z, Chalew SA, McCarter Jr RJ, Meistas M, Kowarski AA. 1985 The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab. 60:513-516.
8. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KKY. 1994 Diagnosis of growth-hormone deficiency in adults. Lancet. 343:1064-1068.
9. Thorner MO, Bengtsson BA, Ho KY, et al. 1995 The diagnosis of growth hormone deficiency (GHD) in adults [letter]. J Clin Endocrinol Metab. 80:3097-3098.
10. Iranmanesh A, Lizzarralde G, Veldhuis JD. 1991 Age and relative adiposity are specific determinants of the frequency and amplitude of GH secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 73:1081-1088.
11. Rudman D. 1985 Growth hormone, body composition, and aging [Review]. J Am Geriatr Soc. 33:800-807.
12. Corpas E, Harman SM, Blackman MR. 1993 Human growth hormone and human aging. Endocr Rev. 14:20-39.
13. Rudman D, Feller AG, Nagraj HS, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
14. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. 1994 Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab. 79:470-479.
15. Jorgensen JOL. 1991 Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocr Rev. 12:189-207.
16. Huhn WC, Hartman ML, Pezzoli SS, Thorner MO. 1993 24-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent CHRP bolus. J Clin Endocrinol Metab. 76:1202-1208.
17. Bowers CY, Sartor AO, Reynolds GA, Badger TM. 1991 On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology. 128:2027-2035.
18. Pong SS, Chaung LYP, Dean DC, Nargund RP, Patchett AA, Smith RG. 1996 Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol. 10:57-61.
19. Smith RG, Cheng K, Schoen WR, et al. 1993 A nonpeptidyl growth hormone secretagogue. Science. 260:1640-1643.
20. Patchett AA, Nargund RP, Tata JR, et al. 1995 Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci USA. 92:7001-7005.
21. Aloi JA, Gertz BJ, Hartman ML, et al. 1994 Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects. J Clin Endocrinol Metab. 79:943-949.
22. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. 1994 Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab. 78:1312-1319.
23. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E486-E493.
24. Veldhuis JD, Carlson ML, Johnson ML. 1987 The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc Natl Acad Sci USA. 84:7686-7690.
25. Van Cauter E. 1988 Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. Am J Physiol. 254:E786-E794.
26. 2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′ ,5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology. 124:2791-2798.
27. Wu D, Chen C, Zhang J, Katoh K, Clarke I. 1994 Effects in vitro of new growth hormone releasing peptide (GHRP-1) on growth hormone secretion from ovine pituitary cells in primary culture. J Neuroendocrinol. 6:185-190.
28. 2-induced growth hormone release from rat primary pituitary cells. Endocrinology. 129:3337-3342.
29. Adams EF, Petersen B, Lei T, Buchenfeider M, Fahlbusch R. 1995 The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by pituitary tumors. Biochem Biophys Res Commun. 208:555-561.
30. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF. 1995 Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secetion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab. 80:942-947.
31. Pombo M, Barreiro J, Penalva A, Peino R, Dieguez C, Casanueva FF. 1995 Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. J Clin Endocrinol Metab. 80:3180-3184.
32. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO. 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 70:975-982.
33. Dickson SL, Leng G, Robinson ICAF. 1993 Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neurosci Lett. 53:303-306.
34. Dickson SL, Leng G, Dyball REJ, Smith RG. 1995 Central actions of peptide and non-peptide growth hormone secretagogues in the rat. Neuroendocrinology. 61:36-43.
35. Guillaume V, Magnan E, Cataldi M, et al. 1994 Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology. 135:1073-1076.
36. Micic D, Popovic V, Kendereski A, Macut D, Casanueva FF, Dieguez C. 1995 Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood. Clin Endocrinol (Oxf). 42:191-194.
37. Chapman IM, Hartman ML, Pezzoli SS, Thorner MO. 1996 Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone releasing peptide (GHRP)-mimetic, L-692,429, in older adults. J Clin Endocrinol Metab. 81:2874-2880.
38. Hartman ML, Pincus SM, Johnson ML, et al. 1994 Enhanced basal and disorderly growth hormone (GH) secretion distinguish acromegalic from normal pulsatile GH release. J Clin Invest. 94:1277-1288.
39. Jansson JO, Isaksson OG, Eden S, Isgaard J, Carlsson L, Ekberg S. 1989 Effects of plasma GH pattern on growth factors and body growth. In: Frisch H, Thorner MO, eds. Hormonal regulation of growth. New York: Raven Press; Serono Symposia vol 58:185-199.
40. Jaffe CA, Ho PJ, Demott-Friberg R, Bowers CY, Barkan AL. 1993 Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J Clin Endocrinol Metab. 77:1641-1647.
41. Cohick WS, Clemmons DR. 1993 The insulin-like growth factors. Annu Rev Physiol. 55:131-153.
42. Fowelin J, Attvall S, Lager I, Bengtsson BA. 1993 Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism. 42:1443-1447.
43. Krentz AJ, Koster FT, Crist DM, et al. 1993 Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J AIDS. 6:245-251.
44. Soroff HS, Pearson E, Green NL, Artz CP. 1960 The effect of growth hormone on nitrogen balance at various levels of intake in burned patients. Surg Gynecol Obstet. 111:259-273.
45. Pape GS, Friedman M, Underwood LE, Clemmons DR. 1991 The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest. 99:1495-1500.
46. Jiang ZM, He GZ, Zhang SY, et al. 1989 Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg. 210:524-525.
47. Arrigo T, Martino F, Lombardo F, et al. 1992 Diagnostic value of growth hormone-releasing hormone tests in children and adolescents with idiopathic growth hormone deficiency. Eur J Pediatr. 151:263-266.
48. Thorner MO, Rochiccioli P, Colle M, et al. 1996 Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. J Clin Endocrinol Metab. 81:1189-1196.
49. Chapman IM, Pescovitz OH, Treep T, et al. Oral administration of the GHRP-mimetic MK-0677 stimulates the GH/IGF-I axis in GH deficient adults [Abstract P3-58]. Proc of the 10th Int Congr of Endocrinol. 1996.